Investor
Genesys Capital
Toronto life sciences venture capital firm. Its University Seed Fund backs pre-seed and seed companies emerging from Canadian universities and hospitals; Sunnybrook and UHN joined at its October 2026 second close.
Key details
- Profile type
- Organization
- Geography
- Canada, Ontario, Toronto
- Stage
- Not publicly stated
- Sector
- Not publicly stated
- Founder groups
- Not publicly stated
- Last verified
- Oct 14, 2026
About Genesys Capital
Genesys Capital invests in biotechnology, pharmaceuticals and medical technology. On October 13, 2026, it announced the second close of the Genesys University Seed Fund, adding Sunnybrook Health Sciences Centre and University Health Network as hospital partners. The fund targets pre-seed and seed life sciences companies emerging from Canadian universities and hospitals. These partners join a first-close group including the University of Toronto, McMaster University, Venture Ontario, the Temerty Group and RBC. The announcement does not disclose the fund’s size or standard investment cheque.
Official source
TorontoStarts does not endorse or rank this record. Confirm current details with the official source.
Check current details